Health Condition 1: E889- Metabolic disorder, unspecified
Conditions
Interventions
Intervention1: Flaxseed supplementation: 30 g of flaxseed will be supplemented daily for a period of 12 weeks along with standard of care in intervention group.
Control Intervention1: Standard of care
Sponsors
AIIMS delhi
Eligibility
Inclusion criteria
Inclusion criteria: MASLD diagnosed on fibroscan or abdominal ultrasound At least one of cardiometabolic criteria: 1.BMI more than or equal to 25 kg/m2 2.FBS more than or equal to 140 mg/dl or Hba1C more than or equal to 5.7 % or on treatment for type 2 diabetes mellitus 3. BP more than or equal to 130/85 or on antihypertensive treatment. 4.Plasma triglyceride more than or equal to 150 mg/dl or on lip[id lowering agents. 5.Plasma HDL less than. 40 mg.dl in males or less than 50 gm/dl in females.
Exclusion criteria
Exclusion criteria: Alcohol consumption more than 20 g/day in females and more than 40 g/day in males. Intake of drugs causing liver steatosis like amiodarone,methotrexate etc. Hepatitis C or Hepatitis B Pregnancy or lactation Allergy to flaxseeds Malabsorption syndromes Hypothyroidism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess improvement in liver steatosis in terms of Fibroscan CAP valueTimepoint: At the end of 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess changes in anthropometric and metabolic parameters like FBS , lipid profileTimepoint: At the end of 12 weeks | — |
Countries
India
Contacts
Public ContactDr Upendra Baitha
AIIMS New Delhi
Outcome results
None listed